Peyrl, A; Chocholous, M; Sabel, M; Lassaletta, A; Sterba, J; Leblond, P; Nysom, K; Torsvik, I; Chi, S; Benesch, M; Jones, N; Holm, S; Nyberg, P; Morse, H; Oberg, A; Leiss, U; Haberler, C; Gojo, J; Azizi, A; Andre, N; Kieran, M; Slavc, I.
A METRONOMIC ANTIANGIOGENIC REGIMEN (MEMMAT) INDUCES SUSTAINED SURVIVAL BENEFIT IN RECURRENT MEDULLOBLASTOMA
PEDIATR BLOOD CANCER. 2022; 69:
[Oral Communication]
Web of Science